Bristol-Myers Squibb Co
Euromonitor International's company profile, Bristol-Myers Squibb Co offers detailed strategic analysis of the company's business, examining its performance in the packaged food market. The report examines company shares by region and sector, brand portfolio and new product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success .
Get immediate access to strategic market analysis when you buy reports online
Chapters: 8 | Tables: 23 | Publication date: Apr 2006
Table of contents
1. INTRODUCTION
1.1 KEY FACTS
Summary 1 Bristol-Myers Squibb Co: Key Facts
2. CORPORATE OVERVIEW
2.1 FINANCIAL PERFORMANCE
Net sales growth driven by favourable foreign currency exchange
Profits and margins down as the end of exclusivity nears
Research and development costs stable but set to rise
Gearing remains high despite rise in shareholders’ equity
Table 1 Bristol-Myers Squibb Co: Financial Summary 2000-2004
2.2 GEOGRAPHIC COVERAGE
Flat domestic sales despite good performances from Enfamil, Plavix and Abilify
Foreign currency translation impact boosts international sales
Plavix and Avapro/Avalide drive growth in other segments
Table 2 Bristol-Myers Squibb Co: Sales by Region 2002-2004
2.3 BUSINESS FOCUS
Shift of focus leads to business divestment
Sales fall in OTC Healthcare brands as Other Healthcare division sees growth
Currency exchange, not volume growth, drives Pharmaceutical growth
Divestment of adult nutritionals leads to divisional decline
Table 3 Bristol-Myers Squibb Co: Sales by Division 2002-2004
Table 4 Bristol-Myers Squibb Co: Breakdown of Other Healthcare Division 2002-2004
Chart 1 Bristol-Myers Squibb Co: % Sales by Division 2004
2.4 INTERIM RESULTS
Exclusivity losses key to pharmaceutical decline
Infant formula drives Nutritionals growth
Consumer Medicines’s decline offsets ConvaTec and Medical Imaging increases
Research and development spending up as marketing focuses on core products
3. STRATEGIC OVERVIEW
3.1 OPERATIONAL STRATEGIES
Internal operations
External operations
Summary 2 Bristol-Myers Squibb Co: New Business Agreements 2004/2005
3.2 MARKET DEVELOPMENT
OTC Healthcare involvement to contract significantly
Smaller interests in packaged food and hot drinks
Table 5 Bristol-Myers Squibb Co: World Sales Performance of Company’s Major Markets
4. PACKAGED FOOD BUSINESS OF BRISTOL-MYERS SQUIBB CO
4.1 PACKAGED FOOD BUSINESS DEVELOPMENT
Pioneer in baby food
Bristol-Myers now absent from the adult packaged food market
5. BRISTOL-MYERS SQUIBB CO PERFORMANCE IN PACKAGED FOOD
5.1 COMPETITIVE CONTEXT
Established presence in baby food
Counting on the WIC programme
5.2 COMPANY WORLD MARKET SHARES
A stable positioning in baby food after losing in adult packaged food
Table 6 Bristol-Myers Squibb Co: World Shares & Rankings in Packaged Food by Sector 2001-2004
5.3 COMPANY SHARES BY REGION AND SECTOR
A US-centred business
Growing business in Asia-Pacific
Intense competition in Latin America
Low penetration elsewhere
Table 7 Bristol-Myers Squibb Co: Regional Shares in Packaged Food by Sector 2004
5.4 MARKETING STRATEGIES
Charity and fundraising
Gifts and promotions
Bristol-Myers Squibb’s marketing startegies are subject to criticism
Baby scholarships
The importance of on-line marketing
5.5 DISTRIBUTION STRATEGIES
6. BRISTOL-MYERS SQUIBB CO PACKAGED FOOD BRAND ASSESSMENT
6.1 BRAND PORTFOLIO
6.2 NEW PRODUCT DEVELOPMENT
Packaging development
6.3 CORE BRANDS
Cal-C-Tose
Table 8 Bristol-Myers Squibb Co: Cal-C-Tose World Shares & Rankings in Dairy Products 2001-2004
Table 9 Bristol-Myers Squibb Co: Cal-C-Tose Regional Shares in Dairy Products 2004
Choco Milk
Table 10 Bristol-Myers Squibb Co: Choco Milk World Shares & Rankings in Dairy Products 2001-2004
Table 11 Bristol-Myers Squibb Co: Choco Milk Regional Shares in Dairy Products 2004
Enfalac
Table 12 Bristol-Myers Squibb Co: Enfalac World Shares & Rankings in Baby Food 2001-2004
Table 13 Bristol-Myers Squibb Co: Enfalac Regional Shares in Baby Food 2004
Enfamil
Table 14 Bristol-Myers Squibb Co: Enfamil World Shares & Rankings in Baby Food 2001-2004
Table 15 Bristol-Myers Squibb Co: Enfamil Regional Shares in Baby Food 2004
7. BRISTOL-MYERS SQUIBB CO PACKAGED FOOD STRATEGIC EVALUATION
7.1 BRISTOL-MYERS SQUIBB CO SECTOR POTENTIAL
Winning formula
Table 16 Bristol-Myers Squibb Co: World Sales Performance of Key Sectors of Involvement 2004
7.2 SWOT ANALYSIS
Strengths
Weaknesses
Opportunities
Threats
7.3 FUTURE PROSPECTS FOR PACKAGED FOOD BUSINESS
Focus on baby food
New product development
Emerging markets
Breast-feeding lobby
8. APPENDICES
8.1 APPENDIX 1 – BRISTOL-MYERS SQUIBB CO BRAND PORTFOLIO
Summary 3 Bristol-Myers Squibb Co: Packaged Food Brands 2004
8.2 APPENDIX 2 – SUBSIDIARIES AND AFFILIATES OF BRISTOL-MYERS SQUIBB CO
Summary 4 Bristol-Myers Squibb Co: Subsidiaries 2004
8.3 APPENDIX 3 – WEBSITES OF BRISTOL-MYERS SQUIBB CO
Summary 5 Bristol-Myers Squibb Co: Websites
8.4 APPENDIX 4 – HISTORY AND CORPORATE DEVELOPMENT
Summary 6 Bristol-Myers Squibb Co: Historical Development
8.5 APPENDIX 5 – COMPANY LOCATIONS
Summary 7 Bristol-Myers Squibb Co: Company Locations